To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
Clinical trial NCT07081256 · COMPLETED
Trial details
- NCT number
- NCT07081256
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-03
- Primary completion
- 2025-08-25
- Enrollment
- 665
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.